Omeros (OMER) Equity Ratio (2010 - 2026)

Omeros' (OMER) quarterly Equity Ratio came in at 0.22 in Q1 2026, up 75.63% year-on-year from 0.13 in Q1 2025, and up 40.55% quarter-over-quarter from 0.37 in Q4 2025.

Omeros (OMER) Equity Ratio (2010 - 2026) Analysis & Trends

Omeros has disclosed Equity Ratio across 17 years of filings, most recently posting 0.22 for Q1 2026.

  • Equity Ratio for Q1 2026 came in at 0.22, up 75.63% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.22 (up 75.63% YoY), and the FY2025 annual result was 0.37, up 43.51% from the prior year.
  • Equity Ratio came in at 0.22 for Q1 2026 at Omeros, up from 0.37 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.14 in Q4 2022 to a low of 1.19 in Q3 2025.
  • The 5-year median for Equity Ratio is 0.16 (2024), against an average of 0.32.
  • Across the five-year window, Equity Ratio soared 835.35% in 2023 and sank 1638.88% in 2024, its largest moves.
  • Omeros' Equity Ratio stood at 0.14 in 2022, then sank by 145.55% to 0.07 in 2023, then slumped by 897.87% to 0.66 in 2024, then surged by 43.51% to 0.37 in 2025, then surged by 40.55% to 0.22 in 2026.
  • The last three Equity Ratio figures came in at 0.22 (Q1 2026), 0.37 (Q4 2025), and 1.19 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 191.07
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 0.98
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 0.04
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.58
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 0.42
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 0.73
9 Abivax 91.96 Bn 91.96 Bn - 0.79
10 Omeros 737.87 Mn 602.55 Mn 9.31 Mn -0.22

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.22
Dec 31, 2025 -0.37
Sep 30, 2025 -1.19
Jun 30, 2025 -1.14
Mar 31, 2025 -0.91
Dec 31, 2024 -0.66
Sep 30, 2024 -0.49
Jun 30, 2024 -0.35
Mar 31, 2024 -0.16
Dec 31, 2023 -0.07
Sep 30, 2023 -0.03
Jun 30, 2023 0.04
Mar 31, 2023 0.10
Dec 31, 2022 0.14
Sep 30, 2022 -0.10
Jun 30, 2022 -0.09
Mar 31, 2022 -0.01
Dec 31, 2021 0.06
Sep 30, 2021 -2.13
Jun 30, 2021 -1.69